Trial Profile
Evaluation of the Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Administered With or Without Yellow Fever Vaccine in US Adults.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Jun 2019
Price :
$35
*
At a glance
- Drugs CYD TDV (Primary) ; Yellow fever vaccine
- Indications Dengue; Yellow fever
- Focus Therapeutic Use
- Sponsors Sanofi; Sanofi Pasteur
- 01 May 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 29 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Dec 2011 New trial record